Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765 · View on ClinicalTrials.gov ↗
Study Summary
The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.
Conditions Studied
Interventions
- OTHER Accelerated medical clearance and surgery
Study Locations (20)
Maryland
- University of Maryland — Baltimore
- Sinai Hospital of Baltimore — Baltimore
Massachusetts
- Tufts Medical Center — Boston
- Lahey Hospital and Medical Center — Burlington
Arizona
- Chandler Regional Medical Center — Chandler
California
- The Regents of the University of California — Davis
Connecticut
- Yale New Haven Hospital — New Haven
Georgia
- Emory University at Grady Memorial Hospital — Atlanta
Michigan
- University of Michigan — Ann Arbor
Minnesota
- Mayo Clinic — Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2021-11-22 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04743765
The ClinicalTrials.gov registry entry for NCT04743765 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Population Health Research Institute, which has 68 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Hip Fractures appearing as the primary indexed condition, and to 1 intervention — of which Accelerated medical clearance and surgery is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT04743765 reports 20 study locations spanning 18 distinct geographic areas — top geographies include Maryland, Massachusetts, Arizona. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT04743765 about?
NCT04743765 is a clinical study titled "HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial". The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also ass...
What is the current status of trial NCT04743765?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,100 participants. The study started on 2021-11-22. Estimated completion is 2027-05-31.
What conditions does trial NCT04743765 study?
This clinical trial studies the following conditions: Hip Fractures, Myocardial Injury. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT04743765?
The interventions under investigation include: Accelerated medical clearance and surgery (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT04743765?
This trial is sponsored by Population Health Research Institute, which has 68 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT04743765 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.